Protein misfolding disorders, such as Alzheimer’s and Parkinson’s diseases and type II diabetes, which are progressive and still incurable, are rapidly becoming the greatest threat to modern healthcare, with over 40 million people worldwide suffering from dementia and over 300 million people from type II diabetes.
To respond to this challenge, the research carried out at the Centre for Misfolding Diseases (CMD) focuses on:
- Understanding the molecular processes underlying diseases related to age and lifestyle;
- Discovering fundamentally new ways of prolonging the health of ageing populations;
- Shifting the emphasis from treatment to the prevention of such conditions;
- Reducing risks and costs associated with them by early diagnosis and timely intervention.